Marc Frahm

Stock Analyst at TD Cowen

(0.10)
# 4,124
Out of 4,784 analysts
16
Total ratings
15.38%
Success rate
-33.08%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Marc Frahm

Sana Biotechnology
Jan 8, 2025
Upgrades: Buy
Price Target: n/a
Current: $1.71
Upside: -
Theravance Biopharma
Aug 6, 2024
Maintains: Hold
Price Target: $10$9
Current: $9.23
Upside: -2.49%
Incyte
May 1, 2024
Maintains: Buy
Price Target: $88$80
Current: $60.60
Upside: +32.01%
Cullinan Therapeutics
Jun 15, 2023
Initiates: Outperform
Price Target: n/a
Current: $8.02
Upside: -
Xilio Therapeutics
Nov 16, 2021
Initiates: Outperform
Price Target: n/a
Current: $0.75
Upside: -
Nuvalent
Aug 23, 2021
Initiates: Outperform
Price Target: n/a
Current: $73.05
Upside: -
Elevation Oncology
Jul 20, 2021
Initiates: Outperform
Price Target: n/a
Current: $0.26
Upside: -
Janux Therapeutics
Jul 6, 2021
Initiates: Outperform
Price Target: n/a
Current: $29.10
Upside: -
Day One Biopharmaceuticals
Jun 21, 2021
Initiates: Outperform
Price Target: n/a
Current: $8.07
Upside: -
Inozyme Pharma
Aug 18, 2020
Initiates: Outperform
Price Target: n/a
Current: $0.92
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $1.61
Upside: -